EPMD is a database containing information (indication, dosages, age of use, clinical studies, etc.) on paediatric drugs authorised by the European Medicines Agency (EMA) under the centralised procedure. Through this tool TEDDY Network supports the transparency of the...
In 2016 TEDDY has developed a survey (launched in October 2016 and closed on April 2017) aimed at collecting information on paediatric trials centres including information on their structural organisation and activities in paediatric research. This action was...
In February 2018, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization in the European Union for Amglidia, a medicine indicated for the treatment of neonatal diabetes mellitus...
The General Assembly of TEDDY – European Network of Excellence for Paediatric Clinical Research took place on January 14th, 2018 in Rome (Italy). The meeting, entitled “A new phase for paediatric clinical research: a play role for TEDDY?”, provided an update on the...
On June 9th, 2016 the Italian Association Contract Reseach Organisation (AICRO) will organise in Milan (Centro Diagnostico Italiano - CDI, the event entitled “Clinical research in paediatrics: opportunities, complexity and new challenges”. Prof. Adriana Ceci,...